AWM
ORTX

Altium Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Altium Wealth Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$13K Hold
2,200
– – ﹤0.01% 372
2022
Q1 		$16K Hold
2,200
– – ﹤0.01% 374
2021
Q4 		$29K Hold
2,200
– – ﹤0.01% 385
2021
Q3 		$51K Buy
+2,200
New +$65.5K ﹤0.01% 372

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Altium Wealth Management's ORTX Position: Q2 2022 in Review

Altium Wealth Management held its Orchard Therapeutics plc American Depositary Shares (ORTX) position steady in Q2 2022 at 2,200 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #372.

Altium Wealth Management first reported a position in ORTX in Q3 2021 and has held it in 4 quarters since. The position peaked at $51K in Q3 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • Altium Wealth Management held 2,200 shares of Orchard Therapeutics plc American Depositary Shares worth $13K as of Q2 2022.
  • Altium Wealth Management left its Orchard Therapeutics plc American Depositary Shares share count unchanged in Q2 2022.
  • Orchard Therapeutics plc American Depositary Shares made up ﹤0.01% of Altium Wealth Management's portfolio in Q2 2022, its #372 holding.
  • Altium Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2021 and has held it in 4 quarters since.
  • Altium Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $51K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.